Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 10558
Gene Symbol: SPTLC1
SPTLC1
0.030 Biomarker phenotype BEFREE Hereditary sensory neuropathy type I (HSN I) is a slowly progressive neurological disorder characterised by prominent predominantly distal sensory loss, autonomic disturbances, autosomal dominant inheritance, and juvenile or adulthood disease onset. 18348718 2008
Entrez Id: 6261
Gene Symbol: RYR1
RYR1
0.030 Biomarker phenotype BEFREE Anaesthesia-induced malignant hyperthermia (MH) may be caused by specific gene defects in the skeletal muscle ryanodine receptor. 7547049 1995
Entrez Id: 10558
Gene Symbol: SPTLC1
SPTLC1
0.030 GeneticVariation phenotype BEFREE We performed linkage analysis with chromosomal markers representing the hereditary sensory neuropathy type I and Charcot-Marie-Tooth disease type 2B loci on an Italian family with a severe distal sensory loss leading to an ulcero-mutilating peripheral neuropathy. 11801401 2002
Entrez Id: 7124
Gene Symbol: TNF
TNF
0.020 Biomarker phenotype BEFREE Multimodality approach was defined as using a combination of medical treatments (anti-TNFs ± immunomodulators ± antibiotics) along with surgical approach (examination under anaesthesia (EUA) ± seton drainage) at diagnosis of CD-pAF. 30226271 2018
Entrez Id: 4907
Gene Symbol: NT5E
NT5E
0.020 AlteredExpression phenotype BEFREE The objective of this prospective randomized trial was to compare the changes in CD39 and CD73 levels in CD4<sup>+</sup> T cells between propofol- and sevoflurane-based anaesthesia during OHS. 29977072 2018
Entrez Id: 627
Gene Symbol: BDNF
BDNF
0.020 Biomarker phenotype BEFREE Halothane anaesthesia increased BDNF and TrkB mRNA bilaterally. 28609560 2017
Entrez Id: 4907
Gene Symbol: NT5E
NT5E
0.020 Biomarker phenotype BEFREE Collaborative development of paediatric ENT, surgery and anaesthesia should be considered to improve ENT-related child health in Africa. 30143398 2018
Entrez Id: 627
Gene Symbol: BDNF
BDNF
0.020 AlteredExpression phenotype BEFREE Here, we hypothesised that H3K9 trimethylation repressed BDNF expression and impaired memory formation or recall during anaesthesia and surgery. 31708739 2019
Entrez Id: 213
Gene Symbol: ALB
ALB
0.020 Biomarker phenotype BEFREE Albumin solutions were increasingly issued to anaesthesia departments (63%; P = 0.005) and was rarely issued to general surgery and orthopaedic departments. 28374467 2017
Entrez Id: 6285
Gene Symbol: S100B
S100B
0.020 AlteredExpression phenotype BEFREE Our results demonstrated that the primary outcome related to S100B level in the inhalation anaesthesia group was significantly lower than in the TIVA group after CPB and 24 hours postoperatively (weighted mean difference (WMD); 95% CI (CI): -0.41(-0.81 to -0.01), -0.32 (-0.59 to -0.05), respectively). 29025825 2017
Entrez Id: 27352
Gene Symbol: SGSM3
SGSM3
0.020 Biomarker phenotype BEFREE However, with a similar level of anaesthesia effects and suitable parameters for mechanical ventilation, patients in the LMA group showed much more stability in the physiological indicators for inflammation and haemodynamics, including white blood cell count (ΔWBC) and percentage of neutrophil granulocytes (ΔNEU%) in the blood as well as heart rate (ΔHR) and mean arterial pressure (ΔMAP). 30069317 2018
Entrez Id: 6285
Gene Symbol: S100B
S100B
0.020 Biomarker phenotype BEFREE <b>Aim:</b> To clarify the impact of general anaesthesia on cognitive function and to study the possible effect of general anaesthesia on serum S100B, the marker of neuronal degeneration. 30590973 2019
Entrez Id: 7124
Gene Symbol: TNF
TNF
0.020 Biomarker phenotype BEFREE One hundred patients admitted for elective AAA repair had plasma levels of interleukin (IL) 1beta, IL-6, IL-10 and tumour necrosis factor (TNF) alpha measured at induction of anaesthesia and 24 h after operation. 12945076 2003
Entrez Id: 154
Gene Symbol: ADRB2
ADRB2
0.020 GeneticVariation phenotype BEFREE β2-Adrenoceptor gene variants affect vasopressor requirements in patients after thoracic epidural anaesthesia. 24366725 2014
Entrez Id: 27352
Gene Symbol: SGSM3
SGSM3
0.020 Biomarker phenotype BEFREE Following completion of treatment, MAP was determined in rats under anaesthesia via carotid artery cannulation. 28024836 2017
Entrez Id: 3060
Gene Symbol: HCRT
HCRT
0.020 Biomarker phenotype BEFREE Injection of orexin-A (100 pmol) into the VTA reduced emergence time [from 949 (118) to 727 (101) s; P=0.0058] and reduced the electroencephalographic burst-suppression ratio (BSR) (26.6 [10.2]% vs 44.3 [6.8]%; P=0.0027) during isoflurane anaesthesia. 31399212 2019
Entrez Id: 3060
Gene Symbol: HCRT
HCRT
0.020 Biomarker phenotype BEFREE Adult and aged Sprague-Dawley rats were used to assess the time to emergence after 30 min isoflurane anaesthesia (1.4 vol%), and differences in the orexinergic systems, including the number of orexinergic neurones, plasma orexin concentrations, and expression of orexin-1 (OX1R) and orexin-2 receptors, compared using immunofluorescence, radioimmunoassay, western blot, and real-time polymerase chain reaction. 30336854 2018
Entrez Id: 154
Gene Symbol: ADRB2
ADRB2
0.020 GeneticVariation phenotype BEFREE In conclusion, our results demonstrate that haplotype variations of the the ADRB2 modulate the haemodynamic response following spinal anaesthesia for caesarean delivery. 22881137 2012
Entrez Id: 213
Gene Symbol: ALB
ALB
0.020 Biomarker phenotype BEFREE Although the plasma albumin concentrations (35.46 ± 4.13 vs 44.10 ± 1.12 mmol/L, respectively, P < .05) and dosage of propofol were significantly lower in the Renal-failure Group than in the Control Group (81.68 ± 18.08 vs 63.07 ± 13.45 μg/kg/min, respectively, P < .05), there were no differences in the context-sensitive half-life and the revival time of anaesthesia between the 2 groups. 29247451 2018
Entrez Id: 55835
Gene Symbol: CENPJ
CENPJ
0.010 Biomarker phenotype BEFREE The surgeon's satisfaction or comfort with the surgical conditions was assessed using a visual analogue scale. rSO<sub>2</sub> level, mean arterial pressure, pulse oxygen saturation, arterial blood gas analysis, intraoperative hypoxaemia, intraoperative use of CPAP during OLV, and awakening time were determined in patients at the following time points: while inhaling air (T<sub>0</sub>), after anaesthesia induction andinhaling 100% oxygen in the supine position under double lung ventilation for five mins (T<sub>1</sub>), at two mins after skin incision (T<sub>2</sub>), at ten mins after skin incision (T<sub>3</sub>), and after the lung recruitment manoeuvres and inhaling 50% oxygen for five mins (T<sub>4</sub>). 28619111 2017
Entrez Id: 4096
Gene Symbol: MAFD2
MAFD2
0.010 Biomarker phenotype BEFREE Compared with the DI group the MDI group had higher success rates of complete sensory block of the ulnar nerve (93 vs 67%, P = 0.002) and complete anaesthesia (80 vs 56%, P = 0.014) at 15 min, whereas the average performance time was significantly longer (5.08 ± 1.41 vs 4.10 ± 0.64 min, P < 0.001) and the number of needle passes was significantly higher (4.40 ± 1.14 vs 2.87 ± 0.79, P < 0.001). 27798452 2017
Entrez Id: 79054
Gene Symbol: TRPM8
TRPM8
0.010 Biomarker phenotype BEFREE Thus, we propose TRPM8 as a new clinical target for diminishing common and serious complications of general anaesthesia. 23943870 2013
Entrez Id: 54600
Gene Symbol: UGT1A9
UGT1A9
0.010 GeneticVariation phenotype BEFREE The aim of our study was to verify the impact of genetic changes c.516G>T in the CYP2B6, c.98T>C in the UGT1A9 and c.1075A>C in the CYP2C9 genes on the individual propofol pharmacokinetic profile in the Polish patients undergoing general anaesthesia. 27826892 2017
Entrez Id: 2395
Gene Symbol: FXN
FXN
0.010 AlteredExpression phenotype BEFREE FXN RNA and protein levels are reduced in patients leading to progressive gait and limb ataxia, sensory loss, reduced tendon reflexes, dysarthria, absent lower limb reflexes, and loss of position and vibration sense. 22764244 2012
Entrez Id: 7879
Gene Symbol: RAB7A
RAB7A
0.010 GeneticVariation phenotype BEFREE In particular, CMT type 2B (CMT2B) neuropathies are characterized by severe sensory loss, often complicated by infections, arthropathy, and amputations. 18272684 2008